Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Stomach Neoplasms × Pravastatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 3 Congenital Abnormalities 3 Leukemia, Myelomonocytic, Acute 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Leukemia 2 Breast Neoplasms 2 Stomach Neoplasms 1 Prostatic Neoplasms 1 Myeloproliferative Disorders 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Chronic 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Deglutition Disorders 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Oxaliplatin 256 Capecitabine 180 Fluorouracil 163 Cisplatin 142 Docetaxel 122 S 1 (combination) 116 Leucovorin 108 Paclitaxel 104 Irinotecan 96 pembrolizumab 83 Trastuzumab 56 apatinib 54 Nivolumab 49 Drug Therapy 39 sintilimab 36 Radiotherapy 34 Bevacizumab 34 Surgical Procedures, Operative 33 Ramucirumab 31 Carboplatin 28 titanium silicide 27 Epirubicin 27 tislelizumab 26 Hyperthermic Intraperitoneal Chemotherapy 26 Cyclophosphamide 24 XELOX 23 Tegafur 21 Folfox protocol 19 Cetuximab 19 Injections 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01038154 2011-06-27

AGIM-1

Hospital Donostia

Phase 4 Unknown

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡